We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

21 hedge funds and large institutions have $55.1M invested in Minerva Neurosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

24% more funds holding

Funds holding: 17 → 21 (+4)

18% more capital invested

Capital invested by funds: $46.7M → $55.1M (+$8.44M)

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
+$339K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$189K
3
BCM
Bridgeway Capital Management
Texas
+$172K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$83.1K
5
SCM
Sterling Capital Management
North Carolina
+$52.2K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$85.1K
2
TRCT
Tower Research Capital (TRC)
New York
-$15K
3
Walleye Trading
Walleye Trading
New York
-$1K
4
Morgan Stanley
Morgan Stanley
New York
-$292
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$16.8M – – –
Federated Hermes
2
Federated Hermes
Pennsylvania
$15.9M – – –
HCMT
3
Highland Capital Management (Texas)
Texas
$8.03M +$339K +8,125 +5%
CAM
4
Cormorant Asset Management
Massachusetts
$6.95M – – –
PA
5
Perceptive Advisors
New York
$4.92M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$595K +$189K +4,531 +59%
DADC
7
D.A. Davidson & Co
Montana
$483K +$17.9K +428 +4%
BCM
8
Bridgeway Capital Management
Texas
$432K +$172K +4,119 +86%
NC
9
Nexthera Capital
New York
$207K +$178K +4,263 New
Goldman Sachs
10
Goldman Sachs
New York
$197K -$85.1K -2,039 -33%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$191K – – –
BFA
12
BlackRock Fund Advisors
California
$151K +$23K +552 +22%
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$97K +$83.1K +1,990 New
SCM
14
Sterling Capital Management
North Carolina
$61K +$52.2K +1,250 New
Citigroup
15
Citigroup
New York
$30K +$26.1K +626 New
BIM
16
BlackRock Investment Management
Delaware
$14K +$877 +21 +8%
BA
17
BlackRock Advisors
Delaware
$11K – – –
UBS Group
18
UBS Group
Switzerland
$11K +$5.97K +143 +154%
Morgan Stanley
19
Morgan Stanley
New York
$9K -$292 -7 -3%
TRCT
20
Tower Research Capital (TRC)
New York
$6K -$15K -359 -77%
Creative Planning
21
Creative Planning
Kansas
$2K +$1.59K +38 New
Walleye Trading
22
Walleye Trading
New York
– -$1K -25 Closed

NERV Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2015, worth a combined $55.1M — up 18% from $46.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NERV positions and 1 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Highland Capital Management (Texas), adding an estimated $339K. The largest seller was Goldman Sachs, cutting an estimated $85.1K.

  • 21 institutional investors held Minerva Neurosciences (NERV) as of Q4 2015, up from 17 in Q3 2015.
  • Funds reported $55.1M of Minerva Neurosciences stock for Q4 2015, up 18% quarter-over-quarter.
  • 5 funds opened new Minerva Neurosciences positions in Q4 2015 and 1 closed out, a net change of +4 holders.
  • The largest Minerva Neurosciences buyer in Q4 2015 was Highland Capital Management (Texas), an estimated $339K added.
  • The largest Minerva Neurosciences seller in Q4 2015 was Goldman Sachs, an estimated $85.1K sold.

Based on aggregated 13F filings for Q4 2015.